Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Meticulously designed for advanced metabolic and endocrine pathway research
The studies may differ in duration, participant characteristics, starting body weight, treatment protocols, discontinuation rates, statistical estimands and approaches to missing data
References Bailyes, E
This selection can be difficult to navigate without doing scientific research
The role of Tirzepatide, dual GIP and GLP-1 receptor agonist, in the management of type 2 diabetes: the SURPASS clinical trials
Nat Med 2025;31:951-962
US$ 27.42
US$ 26.72
US$ 28.44
